摘要
We are not alone. Trillion of microbes （bacteria, fungi, virus and protozoa） take residence on and in our bodies. Despite their large number, their roles in our health had been largely ignored until recently. Advances in sequencing technologies have helped us to realize the diversity and dynamics of microbes associated with our bodies. A number of interna- tional microbiome consortium programs have suggested connections between dysbiosis and a range of human dis- eases, including metabolic syndrome, autoimmune diseases, autism and many others. Furthermore, use of antibiotics has been found to reduce the efficacy of cancer immunotherapies. Currently, the microbiome is attracting enormous research interest internationally and has become a frontier in life sciences.
We are not alone. Trillion of microbes （bacteria, fungi, virus and protozoa） take residence on and in our bodies. Despite their large number, their roles in our health had been largely ignored until recently. Advances in sequencing technologies have helped us to realize the diversity and dynamics of microbes associated with our bodies. A number of interna- tional microbiome consortium programs have suggested connections between dysbiosis and a range of human dis- eases, including metabolic syndrome, autoimmune diseases, autism and many others. Furthermore, use of antibiotics has been found to reduce the efficacy of cancer immunotherapies. Currently, the microbiome is attracting enormous research interest internationally and has become a frontier in life sciences.
